Advancing innovation in drug and alcohol addiction healthcare - Funding Opportunity
- 4 days ago
- 2 min read
Innovate UK New Funding Opportunity
Organisations can apply for a share of £20 million across two competitions. Projects will advance development of pharmaceutical, digital and MedTech tools to improve treatment recovery and prevention of harm and deaths from drug and alcohol addictions.
Opportunity status | Upcoming |
Funders: | |
Funding type: | Grant |
Publication date: | 12 February 2026 |
Opening date: | 16 February 2026 9:30 am UK time |
Closing date: | 6 May 2026 11:00 am UK time |
Eligibility summary
This competition is open to collaborations only
To lead a collaborative project your organisation must be a UK registered business of any size
Description
Innovate UK, on behalf of the Office for Life Sciences (OLS) Addiction Healthcare Goals (AHG) programme will invest a share of up to £20 million in innovative CR&D projects. This is subject to a sufficient number of high-quality applications being received.
The aim of this AHG Catalysing Innovation Awards scheme is to advance innovations for improving treatment outcomes, enhancing recovery and reducing harm and deaths in drug and alcohol addiction healthcare.
Your project should establish efficiency and market readiness of promising innovative pharmaceutical, MedTech or digital interventions and secure regulatory approvals and certification.
Funding is for pharmaceutical, MedTech and digital interventions that can show real world effectiveness and progress towards UK market use. Projects must also secure the regulatory approvals or certificates needed for rollout. By the end of the funded project innovations should have achieved:
necessary regulatory approvals and certification, or work already underway to get them
full market readiness analysis and clear plans for manufacturing and UK rollout
If your proposal is technological, you must include the design and features of your solution and how it will be applied.
